Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients

BACKGROUND: Adjuvant chemotherapy reduces the risk of recurrence of stage III colon cancer (CC). However, more effective prognostic and predictive biomarkers are needed for better treatment stratification of affected patients. Here, we constructed a 55-gene classifier (55GC) and investigated its uti...

Descripción completa

Detalles Bibliográficos
Autores principales: Oki, Eiji, Shinto, Eiji, Shimokawa, Mototsugu, Yamaguchi, Shigeki, Ishiguro, Megumi, Hasegawa, Seiji, Takii, Yasumasa, Ishida, Hideyuki, Kusumoto, Tetsuya, Morita, Masaru, Tomita, Naohiro, Shiozawa, Manabu, Tanaka, Masafumi, Ozawa, Heita, Hashiguchi, Yojiro, Ohnuma, Shinobu, Tada, Sachiyo, Matsushima, Tomoko, Hase, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672629/
https://www.ncbi.nlm.nih.gov/pubmed/34906120
http://dx.doi.org/10.1186/s12885-021-09088-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672629/
https://www.ncbi.nlm.nih.gov/pubmed/34906120
http://dx.doi.org/10.1186/s12885-021-09088-6

Ejemplares similares